Home Cart Sign in  
Chemical Structure| 929622-08-2 Chemical Structure| 929622-08-2

Structure of Bavisant
CAS No.: 929622-08-2

Chemical Structure| 929622-08-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bavisant is a highly selective, orally active antagonist of the human H3 receptor with a mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.

Synonyms: JNJ-31001074

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bavisant

CAS No. :929622-08-2
Formula : C19H27N3O2
M.W : 329.44
SMILES Code : O=C(N1CCN(C2CC2)CC1)C(C=C3)=CC=C3CN4CCOCC4
Synonyms :
JNJ-31001074
MDL No. :MFCD19443732

Safety of Bavisant

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Bavisant

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00890240 Attention Deficit Hyperactivit... More >>y Disorder|Attention Deficit Disorders With Hyperactivity Less << PHASE1 COMPLETED 2025-11-09 -
NCT00890292 Attention Deficit Hyperactivit... More >>y Disorder|Attention Deficit Disorders With Hyperactivity Less << PHASE1 COMPLETED 2025-12-09 -
NCT00915434 Healthy|Pharmacokinetics PHASE1 COMPLETED 2025-11-09 -
NCT00915668 Pharmacokinetics|Drug Interact... More >>ions|Healthy Less << PHASE1 WITHDRAWN 2025-03-11 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.04mL

0.61mL

0.30mL

15.18mL

3.04mL

1.52mL

30.35mL

6.07mL

3.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories